Please login to the form below

Not currently logged in
Email:
Password:

H1N1 vaccines move step closer

GSK's first clinical trial for its adjuvanted pandemic vaccine is underway. Meanwhile, Sanofi Pasteur has submitted a supplemental application for licensing of its H1N1 2009 monovalent vaccine

GlaxoSmithKline's (GSK) first clinical trial for its adjuvanted pandemic vaccine is underway. Meanwhile, Sanofi Pasteur has submitted a supplemental application for licensing of its A(H1N1) 2009 monovalent vaccine to the US Food and Drug Administration (FDA). 

Enrolment for the GSK study has been completed and the clinical trial, being conducted in Germany, will assess the use of the vaccine in healthy adults. Initial data is expected to be available for sharing with regulatory authorities in September. Further trials of the pandemic (H1N1) 2009 adjunvanted vaccine covering infants, children, adults and the elderly will commence over the coming weeks across Europe, Canada and the US.

Sanofi Pasteur's supplemental application follows recent recommendations by the FDA to evaluate the influenza A (H1N1) 2009 monovalent vaccines using the same regulatory process by which it approves new viral strains contained in the annual seasonal influenza vaccines. The supplemental application is expected to expedite the vaccine's licensing process. 

17th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics